Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024
Authors:
- Fabio FernandesFFFabio Fernandes
- Marcus V. SimõesMSMarcus V. Simões
- Edileide de Barros CorreiaECEdileide de Barros Correia
- Fabiana Goulart Marcondes-BragaFMFabiana Goulart Marcondes-Braga
- Otavio Rizzi Coelho-FilhoOCOtavio Rizzi Coelho-Filho
- Cláudio Tinoco MesquitaCMCláudio Tinoco Mesquita
- Wilson Mathias JuniorWJWilson Mathias Junior
- Murillo de Oliveira AntunesMAMurillo de Oliveira Antunes
- Edmundo Arteaga-FernándezEAEdmundo Arteaga-Fernández
- Carlos Eduardo RochitteCRCarlos Eduardo Rochitte
- Felix José Alvarez RamiresFRFelix José Alvarez Ramires
- Silvia Marinho Martins AlvesSASilvia Marinho Martins Alves
Open Access
- 1 January 2024
- journal article
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (7)
Abstract
1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding of its pathogenesis, significant advances in the use of imaging methods, and the more common application of genetic analysis, in addition to a better characterization of the natural history of this myocardial disease, have profoundly reformulated its clinical and prognostic significance. Conversely, these processes were accompanied by the development of new medications addressing molecular mechanisms intrinsically linked to the pathophysiology and pathogenesis [...] 1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding of its pathogenesis, significant advances in the use of imaging methods, and the more common application of genetic analysis, in addition to a better characterization of the natural history of this myocardial disease, have profoundly reformulated its clinical and prognostic significance. Conversely, these processes were accompanied by the development of new medications addressing molecular mechanisms intrinsically linked to the pathophysiology and pathogenesisKeywords
This publication has 338 references indexed in Scilit:
- Association of Obesity With Adverse Long-term Outcomes in Hypertrophic CardiomyopathyJAMA Cardiology, 2020
- Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)JAMA Cardiology, 2019
- Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic CardiomyopathyJAMA Cardiology, 2019
- The Physical Activity Guidelines for AmericansJAMA, 2018
- Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta‐analysisClinical Cardiology, 2018
- Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic CardiomyopathyJAMA, 2017
- Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic CardiomyopathyJAMA Cardiology, 2016
- Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathyCatheterization and Cardiovascular Interventions, 2012
- Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic CardiomyopathyJAMA, 2007
- Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target areaCatheterization and Cardiovascular Interventions, 1999